Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.

Faber MT, Duun-Henriksen AK, Dehlendorff C, Tatla MK, Munk C, Kjaer SK.

Vaccine. 2019 Jan 7;37(2):265-271. doi: 10.1016/j.vaccine.2018.11.030. Epub 2018 Nov 28.

PMID:
30503078
2.

Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.

Baldur-Felskov B, Mwaiselage J, Faber MT, Kjaerem M, de la Cour CD, Munk C, Kahesa C, Iftner T, Rasch V, Kjaer SK.

Trop Med Int Health. 2019 Feb;24(2):229-237. doi: 10.1111/tmi.13184. Epub 2018 Dec 2.

PMID:
30444556
3.

Self-perceived risk of STIs in a population-based study of Scandinavian women.

Guleria S, Faber MT, Hansen BT, Arnheim-Dahlström L, Liaw KL, Munk C, Nygård M, Kjær SK.

Sex Transm Infect. 2018 Nov;94(7):522-527. doi: 10.1136/sextrans-2017-053397. Epub 2018 Mar 9.

PMID:
29523719
4.

Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.

Faber MT, Sand FL, Albieri V, Norrild B, Kjaer SK, Verdoodt F.

Int J Cancer. 2017 Sep 15;141(6):1161-1169. doi: 10.1002/ijc.30821. Epub 2017 Jun 21. Review.

5.

Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014.

Faber MT, Frederiksen K, Jensen A, Aarslev PB, Kjaer SK.

Gynecol Oncol. 2017 Aug;146(2):359-367. doi: 10.1016/j.ygyno.2017.05.015. Epub 2017 May 23.

PMID:
28545689
6.

Risk factors for HIV positivity among more than 3,400 Tanzanian women.

Faber MT, Munk C, Mwaiselage J, Dartell M, Kahesa C, Iftner T, Rasch V, Kjaer SK.

Women Health. 2017 Jul;57(6):650-664. doi: 10.1080/03630242.2016.1202882. Epub 2016 Jul 5.

PMID:
27379612
7.

Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis.

Olesen TB, Svahn MF, Faber MT, Duun-Henriksen AK, Junge J, Norrild B, Kjaer SK.

Gynecol Oncol. 2014 Jul;134(1):206-15. doi: 10.1016/j.ygyno.2014.02.040. Epub 2014 Mar 4. Review.

PMID:
24607284
8.

Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.

Faber MT, Jensen A, Frederiksen K, Glud E, Høgdall E, Høgdall C, Blaakaer J, Kjaer SK.

Cancer Causes Control. 2013 Dec;24(12):2197-206. doi: 10.1007/s10552-013-0296-8.

PMID:
24077761
9.

Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies.

Svahn MF, Faber MT, Christensen J, Norrild B, Kjaer SK.

Acta Obstet Gynecol Scand. 2014 Jan;93(1):6-19. doi: 10.1111/aogs.12254. Epub 2013 Oct 24.

PMID:
24033121
10.

Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.

Rasmussen CB, Faber MT, Jensen A, Høgdall E, Høgdall C, Blaakær J, Kjaer SK.

Cancer Causes Control. 2013 Jul;24(7):1459-64. doi: 10.1007/s10552-013-0216-y. Epub 2013 Apr 25.

PMID:
23615817
11.

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A; Ovarian Cancer Association Consortium.

Cancer Causes Control. 2013 May;24(5):989-1004. doi: 10.1007/s10552-013-0174-4. Epub 2013 Mar 2.

12.

Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.

Baandrup L, Faber MT, Christensen J, Jensen A, Andersen KK, Friis S, Kjaer SK.

Acta Obstet Gynecol Scand. 2013 Mar;92(3):245-55. doi: 10.1111/aogs.12069. Epub 2013 Jan 22. Review.

PMID:
23240575
13.

Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.

Ammundsen HB, Faber MT, Jensen A, Høgdall E, Blaakaer J, Høgdall C, Kjaer SK.

Acta Obstet Gynecol Scand. 2012 Sep;91(9):1094-102. doi: 10.1111/j.1600-0412.2012.01472.x.

PMID:
22646488
14.

Use of dairy products, lactose, and calcium and risk of ovarian cancer - results from a Danish case-control study.

Faber MT, Jensen A, Søgaard M, Høgdall E, Høgdall C, Blaakaer J, Kjaer SK.

Acta Oncol. 2012 Apr;51(4):454-64. doi: 10.3109/0284186X.2011.636754. Epub 2012 Mar 8.

PMID:
22397392
15.

Genital chlamydia, genital herpes, Trichomonas vaginalis and gonorrhea prevalence, and risk factors among nearly 70,000 randomly selected women in 4 Nordic countries.

Faber MT, Nielsen A, Nygård M, Sparén P, Tryggvadottir L, Hansen BT, Liaw KL, Kjaer SK.

Sex Transm Dis. 2011 Aug;38(8):727-34. doi: 10.1097/OLQ.0b013e318214bb9b.

PMID:
21844702
16.

[Smoking among more than 45,000 randomly sampled Danish women and men].

Faber MT, Nielsen A, Kjaer SK.

Ugeskr Laeger. 2010 Oct 4;172(40):2756-61. Danish.

PMID:
20926046
17.

[Personal health contact systems for cancer patients in Danish hospital wards].

Faber MT, Pedersen C, Grønvold M.

Ugeskr Laeger. 2009 Nov 9;171(46):3363-7. Danish.

PMID:
19925743

Supplemental Content

Loading ...
Support Center